Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US court blocks terminally ill patient from access to experimental drug

This article was originally published in SRA

Executive Summary

A US appeals court has ruled in favour of a pharmaceutical company, stating that the company cannot be forced to offer an experimental drug to a terminally ill patient outside the clinical trial process1,2. The court decision reverses an earlier controversial decision by a district court, which created a stir among pharma companies when it ordered PTC Therapeutics - against its objections - to provide the patient access to its investigational drug, PTC124.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS114154

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel